Skip to main content
OpenTrials
Completed

NCT Number: NCT03759275

pMDT in Thoracic Surgery--------For the Baseline Investigation and Technical Preparation Stage

The risk of acute and chronic pain after thoracic surgery is high. The multi-disciplinary postoperative pain management strategy is the best way to control postoperative pain in thoracic surgery. Through nearly one year of experience in implementation of the pMDT in the thoracic surgery department of Peking University People's Hospital, the investigators have summarized the experience in multidisciplinary pain management and promoted this study in multi-centers across the country, hoping that this study can improve the current situation of acute pain management in patients after thoracic surgery, and at the same time, the deficiencies of this clinical protocol can be found out and improved.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking University People's Hospital

Beijing, Beijing Municipality, 100044, China

About this study

The postoperative acute pain refers to the acute pain (usually lasting less than 7 days) that occurs immediately after surgery, and its nature is traumatic pain. It may develop into a chronic pain, such as a neuropathic pain or a mixed pain, if it is not fully controlled at the initial state. It will seriously impact the physiology and psychology of a patient. According to the study, the postoperative acute pain is one of the risks for postoperative complications, and it may result in the death of a patient. However, the alleviation of a postoperative acute pain can shorten the duration of stay in hospital, and reduce the overall cost for treatment of a patient.

The risk of acute and chronic pain after thoracic surgery is high. The multi-disciplinary postoperative pain management strategy is the best way to control postoperative pain in thoracic surgery. Through nearly one year of experience in implementation of the pMDT in the thoracic surgery department of Peking University People's Hospital, the investigators have summarized the experience in multidisciplinary pain management and promoted this study in multi-centers across the country, hoping that this study can improve the current situation of acute pain management in patients after thoracic surgery, and at the same time, the deficiencies of this clinical protocol can be found out and improved.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged between 18 and 75, ASA I-II;
  • Patients undergoing thoracoscopic surgery;
  • Patients who can understand and fill in the self-evaluation;
  • Patients who signed the Informed Consent Form.

Exclusion criteria

  • Pregnant women;
  • Patients with preoperative chronic pain and long-term opioid use;
  • Patients with advanced tumors who have received preoperative chemotherapy or who are expected to receive postoperative chemotherapy.

Treatment and study plan

pMDT(Baseline Investigation)

Other

The pMDT(Baseline Investigation) takes multi-model analgesia as the main technical means. Multimodal perioperative analgesia refers to the combination of analgesics, adjuvant drugs and analgesic techniques with different effects throughout the perioperative period to achieve the best curative effect of reducing postoperative acute and chronic pain.

Primary outcomes

  1. Incidence rate of postoperative pain

    Time frame: Up to 90 days after surgery.

    The percentage of patients with NRS score greater than 3

  2. The degree of patients' satisfaction

    Time frame: 3 days after surgery.

    The degree of patients' satisfaction on pain managements. Patients were asked to give a score from 0-10 (0 means dissatisfied, 10 means very satisfied).

Secondary outcomes

  1. Postoperative duration of stay in hospital

    Time frame: Up to 90 days after surgery.

    The duration when patients stay in hospital after surgery.

  2. Rehospitalization rate

    Time frame: Up to 90 days after surgery.

    The percentage of patients who are rehospitalized.

  3. Postoperative complication incidence rate

    Time frame: Up to 90 days after surgery.

    The percentage of patients with complications after surgery.

Sponsors and collaborators

Lead sponsor

Peking University People's Hospital

Other

Collaborators

  • Anhui Provincial Hospital
  • First Affiliated Hospital of Chongqing Medical University
  • First Affiliated Hospital of Kunming Medical University
  • First Affiliated Hospital of Xinjiang Medical University
  • Fujian Provincial Hospital
  • General Hospital of Shenyang Military Region
  • Guangdong Provincial People's Hospital
  • Hebei Medical University Fourth Hospital
  • Hebei Tumor Hospital
  • Henan Provincial People's Hospital
  • Kunming General Hospital of PLA
  • LanZhou University
  • Lanzhou University Second Hospital
  • Liaoning Cancer Hospital & Institute
  • Peking Union Medical College Hospital
  • Qianfoshan Hospital
  • Renmin Hospital of Wuhan University
  • Second Affiliated Hospital of Nanchang University
  • Shanghai Chest Hospital
  • Shanxi Provincial People's Hospital
  • Southwest Hospital, China
  • The First Affiliated Hospital of Zhengzhou University
  • The People's Hospital of Gaozhou
  • Zhejiang University

Registry information

Official study title

Perioperative Pain Management With Multi-discipline Team(pMDT) in Thoracic Surgery: a Multi-center,Prospective, Observational Study--------For the Baseline Investigation and Technical Preparation Stage

Important dates

Study start
2018
Primary completion
2019
Study completion
2021
First posted
Nov 29, 2018
Registry last updated
Mar 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.